EQT agrees to take QIAGEN private at €46.50 per share
HedgeCo.Net reports that EQT has agreed to take QIAGEN private through a recommended, all-cash voluntary public takeover offer of €46.50 per share. The report states the transaction values the molecular testing company at about €10.8 billion.
Why “Rumor”
- A single, lightly trusted source: HedgeCo.Net
1 independent source group across 1 post · evidence score 40/100. How labels work
What the sources claim
-
EQT agreed to take QIAGEN private via a recommended all-cash voluntary public takeover offer of €46.50 per share.
“EQT has agreed to take QIAGEN private through a recommended, all-cash voluntary public takeover offer of €46.50 per share”
HedgeCo.Net -
The transaction values QIAGEN at about €10.8 billion.
“Valuing It at About €10.8 Billion”
HedgeCo.Net
Sources
More in Treasuries & Companies
Summary and claims extracted by AI with prompt analyze-story@5 on 2026-10-22 10:10 UTC. Labels are computed from the sources, not by the model.